Open Access
BIO Web Conf.
Volume 8, 2017
2016 International Conference on Medicine Sciences and Bioengineering (ICMSB2016)
Article Number 01056
Number of page(s) 7
Section Session I: Medicine
Published online 11 January 2017
  • S.M. Barr, E.M Johnson. Journal of cellular biochemistry. 2001; 81(4):621–38. [CrossRef] [PubMed]
  • A.D. Bergemann, EM Johnson. Molecular and cellular biology. 1992; 12(3):1257–65. [CrossRef] [PubMed]
  • A.D. Bergemann, Z.W. Ma, E.M. Johnson. Molecular and cellular biology. 1992; 12(12): 5673–82. [CrossRef] [PubMed]
  • G.L. Gallia, E.M. Johnson, and K. Khalili. Nucleic Acids Res. 2000; 28(17):3197–205. [CrossRef] [PubMed]
  • E.M. Johnson. Anticancer Res. 2003; 23(3A):2093–100. [PubMed]
  • E.M Johnson, Y. Kinoshita, D.B. Weinreb, et al. J Neurosci Res. 2006; 83(6):929–43. [CrossRef] [PubMed]
  • D.W. Stacey, M. Hitomi, M. Kanovsky, et al. Oncogene. 1999; 18(29):4254–61. [CrossRef] [PubMed]
  • N. Darbinian, G.L. Gallia, J. King, et al. J Cell Physiol. 2001; 189(3):334–40. [CrossRef] [PubMed]
  • K. Lezon-Geyda, V. Najfeld, E.M. Johnson. Leukemia. 2001; 15(6):954–62. [CrossRef] [PubMed]
  • H. Wang, M.K. White, R. Kaminski, et al. Anticancer research. 2008; 28(3A):1441–7. [PubMed]
  • H. Wang, M. Wang, K. Reiss, et al. Cancer biology & therapy. 2007; 6(4):596–602. [CrossRef] [PubMed]
  • S. Haas, J. Gordon, K. Khalili. Molecular and cellular biology. 1993; 13(5):3103–12. [CrossRef] [PubMed]
  • A. Tretiakova, G.L. Gallia, N. Shcherbik, et al. The Journal of biological chemistry. 1998; 273(35):22241–7.
  • K. Khalili, L. Del Valle, V. Muralidharan, et al. Mol Cell Biol. 2003; 23(19):6857–75.
  • J.G. Daigle, K. Krishnamurthy, N. Ramesh, et al. Acta Neuropathol. 2016; 131(4):605–20. [CrossRef] [PubMed]
  • P. Jin, R. Duan, A. Qurashi, et al. Neuron. 2007; 55(4):556–64. [CrossRef] [PubMed]
  • R.J. Hagerman, M. Leehey, W. Heinrichs, et al. Neurology. 2001; 57(1):127–30. [CrossRef] [PubMed]
  • S. Jacquemont, R.J. Hagerman, M. Leehey, et al. American journal of human genetics. 2003; 72(4):869–78. [CrossRef] [PubMed]
  • S.R. Lalani, J. Zhang, C.P. Schaaf, et al. American journal of human genetics. 2014; 95(5):579–83. [CrossRef] [PubMed]
  • D. Hunt, R.J. Leventer, C. Simons, et al. Journal of medical genetics. 2014; 51(12):806–13. [CrossRef] [PubMed]
  • E.M. Johnson, D.C. Daniel, J. Gordon. Journal of cellular physiology. 2013; 228(5):930–7. [CrossRef] [PubMed]
  • M.K. White, E.M. Johnson, K. Khalili. Cell Cycle. 2009; 8(3):1–7. [PubMed]
  • S. Haas, P. Thatikunta, A. Steplewski, et al. J Cell Biol. 1995; 130(5):1171–9. [CrossRef] [PubMed]
  • Z.W. Ma, A.D. Bergemann, E.M. Johnson. Gene. 1994; 149(2):311–4.
  • H. Liu, E.M. Johnson. Nucleic Acids Res. 2002; 30(11):2417–26. [CrossRef] [PubMed]
  • N. Darbinian, G.L. Gallia, K. Khalili. J Cell Biochem. 2001; 80(4):589–95. [CrossRef] [PubMed]
  • T. Kong, M. Scully, C.S. Shelley, et al. J Immunol. 2007; 179(3):1934–41.
  • S. Hokkanen, H.M. Feldmann, H. Ding, et al. Hum Mol Genet. 2012; 21(3):473–84. [CrossRef] [PubMed]
  • D. Hunt, R.J. Leventer, C. Simons, et al. J Med Genet. 2014; 51(12):806–13.
  • K. Shimojima, B. Isidor, C. Le Caignec, et al. American journal of medical genetics Part A. 2011; 155A (4):732–6. [CrossRef] [PubMed]
  • C. Mareni, B.R. Migeon. American journal of human genetics. 1981; 33(5):752–61. [PubMed]
  • P.J. Hagerman, R.J. Hagerman. Mental retardation and developmental disabilities research reviews. 2004; 10(1):25–30. [CrossRef] [PubMed]
  • R.J. Hagerman, B.R. Leavitt, F. Farzin, et al. American journal of human genetics. 2004; 74(5):1051–6. [CrossRef] [PubMed]
  • R.J. Hagerman, M.Y. Ono, P.J. Hagerman. Current opinion in psychiatry. 2005; 18(5):490–6. [CrossRef] [PubMed]
  • C.M. Greco, R.J. Hagerman, F. Tassone, et al. Brain: a journal of neurology. 2002; 125(Pt 8):1760–71. [CrossRef]
  • H. Tan, A. Qurashi, M. Poidevin, et al. Human molecular genetics. 2012; 21(1):57–65. [CrossRef] [PubMed]
  • A. Qurashi, W. Li, J.Y. Zhou, et al. PLoS genetics. 2011; 7(6):e1002102.
  • S.T. Warren, and S. L. Sherman, (2001). The fragile X syndrome. In The Metabolic & Molecular Bases of Inherited Disease, C.R. Scriver, A.L. Beaudet, D. Valle, B. Childs, K.W. Kinzler, and B. Vogelstein, eds. (New York: McGraw-Hill Companies), pp. 1257–1290.
  • S. Sherman, (2002). Epidemiology. In Fragile X Syndrome: Diagnosis, Treatment and Research, R.J. Hagerman, ed. (Baltimore, MD: The Johns Hopkins University Press), pp. 136–168.
  • J. Chai, Y. Li, H. Wang, and J. Cui, Archives of medicine, 2015, Vol. 7 No. 4:5.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.